Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Medtronic announced today that it brought its Affera mapping and ablation system into clinical use for the first time in ...

As a technical fellow for Medtronic, Yanina Grinberg works on pacemakers and implantable cardiac defibrillators. A 16-year veteran of the medtech giant, she drives innovation and impact at ...

Medtronic plc (NYSE ... Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable ...

Medtronic plc (NYSE:MDT – Get Free Report) has received a consensus rating of “Hold” from the sixteen ratings firms that are ...

The global defibrillator market was valued at US$ 7.2 billion in 2021 and is estimated to expand at a compound annual growth ...

We report the case of a 51-year-old female who underwent placement of an implantable cardiac defibrillator (ICD) and a biventricular pacemaker and who immediately postoperatively experienced ...

Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps ...

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...